• Company Responses to Drug Abuse from AMA's Nationwide Survey

      Masi, Dale A. (Saranac Lake, N.Y. : Amacom-P, 1987-03)
      The American Management Association (AMA) developed a systematic study designed to obtain baseline data on the company response to drug abuse, with a particular emphasis on drug screening. In the wake of public concern about the extent of drug abuse and controversy regarding the use of drug testing, the AMA survey offers a compelling first look into the range and effectiveness of methods used by companies to address the growing problem of drug abuse.
    • Monitoring and Toxicology

      Hamilton, Christopher, Ph.D., M.P.A. (2016-02-09)
      Recovery and public health, safety, and welfare protection are physician health program (PHP) and alternative to discipline (ATD) foundations. Abstinence is a proxy to these foundations and is fundamental to monitoring programs. PHP and ATD research recommend up to weekly participant testing. Toxicology volume in monitoring necessitates a thorough understanding of panels, reliability, and varying testing methods. Session will cover panel composition with shifting drugs of availability, interpreting medical review officer reports, techniques to circumvent common donor excuses, and when to consider an alternative testing method. The toxicology experience in monitoring has generalizability to employee assistance programs.
    • Workplace drug testing programs: A review of research and a survey of worksites

      Blum, Terry C.; Fields, Dail L.; Milne, Stuart H.; Spell, Chester S. (Employee Assistance Professional Association (EAPA), 1992)
      Private sector employees are experiencing increased governmental regulation and pressure to utilize drug testing for job applicants and employees at their worksites. Public policy is espousing organizationally sponsored drug testing as beneficial not only to the workplace but to society in general. Little rigorous research has been conducted, however, to support the foundations of this public policy. This paper reviews the extant research on this topic and then presents results of a study conducted at 342 worksites. The data describe various facets of drug testing end related practices and compares them over several organizational characteristics. Implications based on the study's results are presented for those involved with drug testing programs.